![PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/17a2351e779a6f8131c6fa7a971a5f8a2dc17df2/7-Figure2-1.png)
PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar
![A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5801-3/MediaObjects/12885_2019_5801_Fig1_HTML.png)
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text
![Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01632-2/MediaObjects/41416_2021_1632_Fig1_HTML.png)
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig5_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Study design. (A) The dose-escalation design included two main steps... | Download Scientific Diagram Study design. (A) The dose-escalation design included two main steps... | Download Scientific Diagram](https://www.researchgate.net/publication/38077856/figure/fig1/AS:315172368470016@1452154356606/Study-design-A-The-dose-escalation-design-included-two-main-steps-with-ridaforolimus.png)
Study design. (A) The dose-escalation design included two main steps... | Download Scientific Diagram
![Amazon | Dosage Form Design Parameters: Volume II (Advances in Pharmaceutical Product Development and Research) | Tekade PhD, Rakesh K. | Biological Sciences Amazon | Dosage Form Design Parameters: Volume II (Advances in Pharmaceutical Product Development and Research) | Tekade PhD, Rakesh K. | Biological Sciences](https://m.media-amazon.com/images/I/51dZXZ5JOOL._SX598_BO1,204,203,200_.jpg)
Amazon | Dosage Form Design Parameters: Volume II (Advances in Pharmaceutical Product Development and Research) | Tekade PhD, Rakesh K. | Biological Sciences
![Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2451865418301017-gr1.jpg)